Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...

Q2 Holdings has introduced Q2 Code, a new AI-powered development environment built in collaboration with Anthropic and Amazon Web Services, signaling a deeper shift in how software is created inside ...

GPT-Rosalind, a specialized AI model developed by OpenAI, focuses on life sciences and biomedical research. The launch ...

European Frontrunners Columnist, Cheryl Barton, focuses on European biotechs leveraging AI, multi-omics, and cell therapies to address the root causes of cardiovascular disease, driving a market ...

Investor interest for AI chip startups is rising, but big challenges remain for the nascent sector.

Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers SAN ...

The rush to build data centers across Pennsylvania is producing uncertainty, confusion, or a lack of transparency in ...

The Centre’s move to fast-track women’s reservation linked with delimitation has raked up a controversy and widened a ...

Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion ...

Following the presentation on April 19, 2026 from 2:00–5:00 PM PT, the poster titled “PLK1 inhibitor onvansertib potentiates the antitumor efficacy of trastuzumab deruxtecan (T-DXd) and reverses its ...